EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells
- 1 April 2016
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1862 (4) , 670-678
Abstract
No abstract availableKeywords
Funding Information
- Oslo University Hospital
- University of Oslo
- South-Eastern Norway Regional Health Authority (2014090)
This publication has 41 references indexed in Scilit:
- Tissue factor-driven thrombin generation and inflammation in atherosclerosisThrombosis Research, 2012
- Hypoxia: Adapting to High Altitude by Mutating EPAS-1 , the Gene Encoding HIF-2αHigh Altitude Medicine & Biology, 2011
- HIF-1 and HIF-2 Transcription Factors - Similar but Not IdenticalMolecules and Cells, 2010
- Vascular-Directed Tissue Factor Pathway Inhibitor Overexpression Regulates Plasma Cholesterol and Reduces Atherosclerotic Plaque DevelopmentCirculation Research, 2009
- Thin-Walled Microvessels in Human Coronary Atherosclerotic Plaques Show Incomplete Endothelial JunctionsJACC, 2009
- Is thrombin a key player in the 'coagulation-atherogenesis' maze?Cardiovascular Research, 2009
- Accelerated atherogenesis and neointima formation in heparin cofactor II–deficient miceBlood, 2007
- Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell CarcinomaMolecular and Cellular Biology, 2005
- Arterial Neovascularization and Inflammation in Vulnerable PatientsCirculation, 2004
- Expression of Tissue Factor in High-Grade Carotid Artery StenosisStroke, 2001